Effect of Leg Elevation on Prevention of Intraoperative Hypotension During Beach Chair Position

December 26, 2019 updated by: Jin-Tae Kim, Seoul National University Hospital

The Effect of Leg Elevation on the Prevention of Intraoperative Hypotension During Shoulder Surgery in the Beach Chair Position

The aim of this study is to evaluate the effect of leg elevation on the prevention of intraoperative hypotension during shoulder surgery in the Beach-chair position. patients undergoing shoulder surgery in the Beach-chair position will be randomly assigned to Group L (with leg elevation) or Group C (no intervention). The primary outcome is the incidence of intraoperative hypotension (mean blood pressure < 60mmHg or systolic blood pressure < 80% of baseline). Secondary outcomes are the incidence of intraoperative cerebral desaturation (cerebral oxygen saturation < 80% of baseline, longer than 30 seconds), total amounts of administered inotropic agents, and systolic blood pressure, heart rate, and cerebral oxygen saturation at various time points.

Study Overview

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 110-744
        • Seoul National University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adult patients undergoing shoulder surgery in the beach chair position

Exclusion Criteria:

  • Patients with myocardial infarction
  • Patients with pacemaker
  • Patients with cerebrovascular disease
  • patients with arteriovenous fistula at the opposite arm
  • Patients with autonomic nerve disorders
  • Patients with hip or knee joint disorder limiting hip or knee flexion
  • BMI > 30 kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group L
leg elevation during the beach chair position
Patients' leg will be raised by a pillow under both legs and the hip and knee joints will be flexed 45 degrees to position both knees at the heart level.
No Intervention: Group C
Patients' leg will be straightened without any intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of intraoperative hypotension
Time Frame: From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)
Mean blood pressure < 60 mmHg or systolic blood pressure < 80% of baseline
From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of intraoperative cerebral desaturation
Time Frame: From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)
Cerebral oxygen saturation < 80% of baseline longer than 30 seconds
From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)
Total amounts of administered inotropic agents
Time Frame: From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)
Total amounts of administered inotropic agents after the Beach-chair positioning
From beach chair positioning to the end of surgery (average of 1 hour up to 2 hours)
Systolic blood pressure
Time Frame: before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
Systolic blood pressure in mmHg at multiple time-points
before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
Heart rate
Time Frame: before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
Heart rate in bpm at multiple time-points
before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
Peripheral oxygen saturation
Time Frame: before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
Peripheral oxygen saturation in percentage at multiple time-points
before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
Cerebral oxygen saturation
Time Frame: before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning
Cerebral oxygen saturation in percentage at multiple time-points
before induction(baseline) / before the Beach-chair positioning / 1,5,30 and 60 minutes after the Beach-chair positioning

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 24, 2018

Primary Completion (Actual)

December 11, 2019

Study Completion (Actual)

December 21, 2019

Study Registration Dates

First Submitted

December 26, 2017

First Submitted That Met QC Criteria

January 5, 2018

First Posted (Actual)

January 8, 2018

Study Record Updates

Last Update Posted (Actual)

December 27, 2019

Last Update Submitted That Met QC Criteria

December 26, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Sharing Time Frame

IPD will be made available after article publication, for 3 years from the study completion.

IPD Sharing Access Criteria

Proposals should be directed to the corresponding author and will be reviewed by the study group. Only requests that have a methodologically sound proposal and whose proposed use of the data has been approved by the independent review committee will be considered.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)
  • Clinical Study Report (CSR)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Ischemia

Clinical Trials on leg elevation

Subscribe